Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Siemens’ Integration Of PET Imaging Partner CTI Follows Expanded Coverage

This article was originally published in The Gray Sheet

Executive Summary

Siemens' $1 bil. acquisition of CTI Molecular Imaging will allow vertical integration of positron emission tomography (PET) imaging system production, consummating an 18-year collaboration

You may also be interested in...



ProNova Preps Its Next-Gen SC360 For Smaller, Cheaper Era Of Proton Therapy

The system, which developers hope to launch in the U.S. in 2015 following completion of a 510(k) submission to FDA, will cost about $50 million for a two-room configuration, and the gantry will weigh 15 tons, well under the typical 110-220-ton weight of most systems, according to ProNova.

Siemens Won $1.86 Bil. DPC Deal By Outbidding Two Other Firms

Siemens' successful bid to acquire Diagnostic Products Corp. earlier this spring was more than a year in the making, according to a recent DPC merger proxy statement

Siemens Won $1.86 Bil. DPC Deal By Outbidding Two Other Firms

Siemens' successful bid to acquire Diagnostic Products Corp. earlier this spring was more than a year in the making, according to a recent DPC merger proxy statement

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel